Funding agencies: This study was supported by Novartis Pharma AG.
Version of Record online: 11 OCT 2011
Copyright © 2011 Movement Disorder Society
Volume 26, Issue 13, pages 2335–2342, November 2011
How to Cite
Brockmann, K., Gröger, A., Di Santo, A., Liepelt, I., Schulte, C., Klose, U., Maetzler, W., Hauser, A.-K., Hilker, R., Gomez-Mancilla, B., Berg, D. and Gasser, T. (2011), Clinical and brain imaging characteristics in leucine-rich repeat kinase 2–associated PD and asymptomatic mutation carriers. Mov. Disord., 26: 2335–2342. doi: 10.1002/mds.23991
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 22 NOV 2011
- Version of Record online: 11 OCT 2011
- Manuscript Accepted: 29 AUG 2011
- Manuscript Revised: 13 AUG 2011
- Manuscript Received: 30 DEC 2010
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.